£30k
−54%vs Dec 2024Active15373740Private limited companyCambridge
OLIGOTUNE LTD
Significant control: Loic Maurice René Jean Roux (25–50%), Cancer Research Technology Ltd (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Oligotune Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
OLIGOTUNE LTD is an active private limited company (company number 15373740) incorporated on 28 December 2023, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 September 2025, showing net assets of £30k and cash of £11k, with 2 employees on average. Net assets fell 54% on the prior period (£66k).
Peer position · net assets
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Dr Loic Maurice René Jean Roux
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Cancer Research Technology Ltd
- owns 25–50% of shares
- holds 25–50% of voting rights
- Deep Science Ventures Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 28 December 20232 yrs ago
- Next accounts due
- 30 June 2027in 250 days
- Confirmation statement due
- 11 January 2027in 80 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£11k
−85%vs Dec 2024Not reported
2
−50%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £30k | £11k | — | £3,420 | — | — | 2 |
| 31 December 2024 | £66k | £72k | — | £25k | — | — | 4 |
Current ratio9.36Current assets ÷ creditors within one year
Cash per employee£5,582Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £30,219 at 30 September 2025
- Net assets down 25% or more on the prior period-54.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 9.36
- Incorporated two to five years agoIncorporated 28 December 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 250 days
- Confirmation statement duein 80 days
- Accounts period endNet assets £30k · small accounts
- Accounts period endNet assets £66k · small accounts
- Incorporated
08
Similar companies in Cambridge
- ROUTLEDGE BIOMEDICAL CONSULTING LIMITEDWhittlesford · inc. Dec 2023
- AGENOME LTDCambridge · inc. Dec 2023
- PETALION THERAPEUTICS LIMITEDCambridge · inc. Dec 2023
- EXIGENT THERAPEUTICS LIMITEDCambridge · inc. Dec 2023
- SAGA DIAGNOSTICS UK LIMITEDCambridge · inc. Dec 2023
- AMBROSE HEALTHCARE (HOLDINGS) LTDCambridge · inc. Dec 2023
All companies incorporated on 28 December 2023 · in Dec 2023.
09
Reminders for OLIGOTUNE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.